# Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.

> **NCT00367211** · PHASE3 · COMPLETED · sponsor: **POZEN** · enrollment: 400 (—)

## Conditions studied

- Osteoarthritis
- Rheumatoid Arthritis
- Ankylosing Spondylitis

## Interventions

- **DRUG:** PN 200 tablets (500 mg naproxen and 20 mg omeprazole)
- **DRUG:** Naproxen 500 mg tablets (PN 200 minus omeprazole)

## Key facts

- **NCT ID:** NCT00367211
- **Lead sponsor:** POZEN
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 400 (—)
- **Last updated:** 2008-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00367211

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00367211, "Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00367211. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*